BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1781 related articles for article (PubMed ID: 15642275)

  • 1. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
    Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
    Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
    Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
    el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
    Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.
    Abbas D; Ezzat Y; Hamdy E; Gamil M
    Lupus; 2012 Jan; 21(1):103-10. PubMed ID: 21976404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.